Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial-Reference-Cited by-同舟云学术

Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial

Published:2002-07 Issue:1 Volume:37 Page:9-14
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Grigorescu Alexandru C.,Draghici Ioana N.,Nitipir Cornelia,Gutulescu Nicolae,Corlan Emil

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference13 articles.

1. Textbook of medical oncology;Cavalli,1997

2. A phase I study of gemcitabine and carboplatin in non-small cell lung cancer;Carmichael;Sem. Oncol.,1996

3. GPower: a general power analysis program;Erdfelder;Behav. Res. Methods Instrum. Comput.,1996

4. Vinblastin plus cisplatin in advanced non-small cell lung cancer: lack of advantage for vinblastine infusion schedule;Huberman;Cancer Treat. Rep.,1986

5. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer: a study of the Eastern Cooperative Oncology Group;Bonomi;J. Clin. Oncol.,1989

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status;Cochrane Database of Systematic Reviews;2023-07-07

2. Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer;European Respiratory Journal;2018-11-28

3. Frontline Systemic Therapy Options in Nonsmall Cell Lung Cancer;IASLC Thoracic Oncology;2018

4. Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non–Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group;Clinical Lung Cancer;2016-11

5. Synergistic cytotoxicity of ampelopsin sodium and carboplatin in human non-small cell lung cancer cell line SPC-A1 by G1 cell cycle arrested;Chinese Journal of Integrative Medicine;2016-06-14